<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 of 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 30, 1998
--------------------------
SPECTRUM LABORATORIES, INC.
---------------------------
(Exact name of Registrant as specified in its charter)
Delaware 0-9478 95-3557539
- --------------------------------------------------------------------------------
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation or organization) Identification No.)
23022 La Cadena Drive, Laguna Hills, California 92653
- --------------------------------------------------------- -----
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (949) 581-3500
--------------
Not Applicable
- -------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS
The Company has entered into a Reorganization Agreement
("Reorganization Agreement") with Spectrum Medical Industries, Inc., a
California corporation ("SMI"). The Reorganization Agreement was dated as of
September 30, 1998, subject to tax clearance by the California Department of
Taxation. Such tax clearance was received on November 3, 1998. Pursuant to the
Reorganization Agreement, SMI was merged into the Company and all SMI
shareholders received shares of the Company at the rate of 98 shares of the
Company's common stock for each share of SMI common stock. The merger was
unanimously approved by the Boards of Directors of both companies. Reports
prepared by independent advisors and audited and interim financial statements
were reviewed by the respective boards to determine the value of SMI with
respect to the value of SLI. The exchange rate for the shares was fixed after
agreement as to such value and with respect to the capitalization of each
entity. The transaction was approved by all of the shareholders of SMI and 92%
of the shareholders of the Company. No general solicitation of consent for the
Company's shareholders is required under Delaware law. Under Delaware law, no
appraisal rights are available to the Company's shareholders.
Roy T. Eddleman, Chief Executive Officer and a Director of the
Company, owned 95% of the outstanding shares of SMI prior to the merger. SMI
owned, prior to the transaction, 79.9% of the outstanding shares of the Company
and Roy Eddleman and Thomas Girardi, the sole shareholders of SMI, each owned
approximately 6% of the outstanding shares of the Company. No consideration
other than shares was exchanged. As a result of the transaction, shareholders of
SMI increased their holdings of the Company from approximately 92% to
approximately 98%. The Company intends to continue the operation of SMI's
business which is the manufacture of medical and laboratory equipment. Prior to
the merger, the Company supplied SMI with a number of membrane products used in
the equipment assembled and sold by SMI.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
a. FINANCIAL STATEMENTS OF BUSINESS ACQUIRED.
It is impracticable for the Company to provide the required financial
statements on the date this report is being filed. The Company intends to file
the required financial statements under cover of Form 8-K/A as soon as
practicable, but not later than 60 days after the date this report must have
been filed.
-2-
<PAGE>
b. PRO FORMA FINANCIAL INFORMATION.
It is impracticable for the Company to provide the required pro forma
financial information on the date this report is being filed. The Company
intends to file the required financial statements under cover of Form 8-K/A as
soon as practicable, but no later than 60 days after the date this report must
have been filed.
c. EXHIBITS
The Reorganization Agreement between Spectrum Medical Industries, Inc.
and the Company is attached hereto as Exhibit 2.
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
SPECTRUM LABORATORIES, INC.
Date: November 16, 1998 By: /s/ Roy T. Eddleman
-------------------------
Roy T. Eddleman
Chairman and Chief Executive Officer
-3-
<PAGE>
Exhibit 2
---------
REORGANIZATION AGREEMENT
This Agreement dated as of September 30, 1998 by and between Spectrum
Laboratories, Inc., a Delaware corporation ("SLI") and Spectrum Medical
Industries, Inc., a California corporation ("SMI").
WHEREAS, SLI sells various medical and laboratory products to SMI and SMI
sells various laboratory and medical products to SLI;
WHEREAS, SLI supplies the membranes used in a majority of SMI's membrane
based products;
WHEREAS, the Board of Directors of SLI and SMI have each determined that
the long term interests of the shareholders of both companies can best be served
by combining the companies in a merger; and
WHEREAS, SMI and SMI's shareholders own collectively approximately 92% of
the issued and outstanding shares of SLI;
NOW, THEREFORE, the parties agree as follows:
1. MERGER. SLI and SMI each adopt the Plan of Merger attached hereto as
Exhibit A, whereby the Companies are merged, the ownership rights of SMI
shareholders are terminated and SMI shareholders receive 98 shares for each
share of SMI common stock.
2. BUSINESS. SLI shall continue the business of SMI.
<PAGE>
3. EFFECTIVE DATE. This Agreement shall be effective as of September 30,
1998 subject to the consent of the California Department of Taxation.
4. GOVERNING LAW. This Agreement shall be governed by the laws of Delaware.
In witness whereof, the parties hereto have executed this Agreement as of
September 30, 1998.
SPECTRUM MEDICAL INDUSTRIES, INC.
By:
-----------------------------------------
Roy T. Eddleman, Chief Executive Officer
SPECTRUM LABORATORIES, INC.
By:
-----------------------------------------
Roy T. Eddleman, Chief Executive Officer
<PAGE>
Exhibit A
---------
PLAN OF MERGER
PLAN OF MERGER providing for the merger of Spectrum Medical Industries,
Inc. a California corporation ("California Corp") into Spectrum Laboratories,
Inc., a Delaware Corporation ("Delaware Corp.") (California Corp. and Delaware
Corp. being hereinafter sometimes individually referred to as a "Constituent
Corporation" and collectively as the "Constituent Corporations").
WITNESSETH
This Plan of Merger provides for the Merger of California Corp. into
Delaware Corp. (the "Merger") pursuant to the provisions of the California
Corporation Law and the Delaware Corporate Law, with Delaware Corp. as the
surviving corporation (hereinafter sometimes referred to as the "Surviving
Corporation"), The terms and conditions of the proposed Merger, including the
manner and basis of converting, or the cash to be paid or delivered in exchange
for, shares of each Constituent Corporation are and shall be as follows:
ARTICLE 5. MERGER: CERTIFICATE OF INCORPORATION: BY-LAWS; DIRECTORS: OFFICERS
- -----------------------------------------------------------------------------
a. MERGER. At the Effective Time of the Merger (as hereinafter defined)
California Corp. shall be merged into Delaware Corp. and its separate existence
shall cease. Thereafter, Delaware Corp., as the SURVIVING Corporation, shall,
consistent with its Certificate of Incorporation, possess all of the rights,
privileges, immunities, powers and purpose of each of the Constituent
Corporations, shall be vested with all the property, real and persons, causes of
action and every other asset of each of the Constituent Corporations; and shall
assume and be liable for all the liabilities, obligations and penalties of each
of the Constituent Corporations.
b. CERTIFICATE OF INCORPORATION OF SURVIVING CORPORATION. At the Effective
Time of the Merger of the Certificate of Incorporation of Delaware Corp. shall
be the Certificate of Incorporation of the Surviving Corporation (subject to
amendment from time to time thereafter in the manner provided by law).
c. BY-LAWS OF SURVIVING CORPORATION. The By-Laws of Delaware Corp. as in
effect prior to the Effective Time of the Merger shall become and continue to be
the By-Laws of the Surviving Corporation until thereafter duly modified, amended
or repealed.
d. DIRECTORS AND OFFICERS OF SURVIVING CORPORATION. The directors and
officers of the Surviving Corporation, each of whom shall hold office from the
Effective Time of the Merger until his respective successor is duly elected or
appointed in the manner provided in the Certificate of Incorporation and/or
By-Laws of the Surviving Corporation or as otherwise provided by law, shall be
those persons who are at the Effective Time of the Merger directors and officers
of Delaware
<PAGE>
Corp. If at the Effective Time of the Merger any vacancy or vacancies shall
exist in the directors or officers of the Surviving Corporation, such vacancy,
or vacancies may thereafter be filled in the manner provided in the By-Laws of
the Surviving Corporation.
ARTICLE 6. CONVERSION OF AND CASH PAYABLE FOR SHARES OF CONSTITUENT CORPORATIONS
- --------------------------------------------------------------------------------
a. SHARES OF CALIFORNIA CORP. At the Effective Time of the Merger, the
holders of all of the then issued and outstanding shares of California Corp.
Common Stock shall forthwith be entitled to receive ninety-eight (98) shares of
Common Stock of the Surviving Corp., and all shares of California Corp. shall
automatically be canceled, terminated and retied and shall cease to exist and
the holders of such shares shall cease to have any rights with respect thereto
other than to receive shares of Delaware Corp. therefore as provided.
b. SURRENDER OF CALIFORNIA CORP. CERTIFICATES. Following the Effective Time
of the Merger, each holder of shares of California Corp. Common Stock
outstanding at the Effective Time of the Merger upon surrender of his
certificate(s) therefor to, and in conformance with such reasonable requirements
as may be established by, the Surviving Corporation, shall be entitled to
receive shares of Delaware Corp. promptly following receipt thereof (together
with such letters of transmittal and other documents as may reasonably be
required) by the Surviving Corporation.
ARTICLE 7. EFFECTIVE TIME OF THE MERGER: MODIFICATION: ABANDONMENT
- ------------------------------------------------------------------
a. EFFECTIVE TIME OF THE MERGER. The Merger provided for herein shall
become effective upon the filing of an appropriate Certificate of Merger by the
Department of State of California and by the Secretary of the State of Delaware
or at such later date as may be set forth in such Certificate of Merger, the
time and date at which the Merger so becomes effective being herein referred to
as the "Effective Time of the Merger."
b. MODIFICATION. At any time prior to the filing of the Certificate of
Merger, whether before or after adoption of this Plan of Merger by the
affirmative vote of two-thirds of the respective shareholders of the Constituent
Corporations in accordance with the California Corporation Law, this Plan of
Merger may be modified, amended or supplemented in such manner as may be
authorized or approved by the respective Board of Directors of the Constituent
Corporation.
c. ABANDONMENT. Notwithstanding approval by the shareholders of the
Constituent Corporations, this Plan of Merger may be terminated and the Merger
provided for herein abandoned at any time prior to the filing of the Certificate
of Merger by action of the respective boards of directors of either California
Corp. or Delaware Corp.
